115 related articles for article (PubMed ID: 7758987)
1. The impact of antiviral therapy with zidovudine: a retrospective study on HIV-positive hemophiliacs in Italy. Italian Group of Congenital Coagulopathies.
Arcieri R; Puopolo M; Baudo F; Chiarotti F; De Rosa V; Schinaia N; Mori PG; Ghirardini A
Haematologica; 1995; 80(1):25-30. PubMed ID: 7758987
[TBL] [Abstract][Full Text] [Related]
2. Clinical factors associated with progression to AIDS in the Italian cohort of HIV-positive hemophiliacs. G.I.C.C. Gruppo Italiano Coagulopatie Congenite.
Schinaia N; Ghirardini AM; Mazzucconi MG; Tagariello G; Morfini M; Chiarotti F
Thromb Haemost; 1994 Jul; 72(1):33-8. PubMed ID: 7974372
[TBL] [Abstract][Full Text] [Related]
3. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
[TBL] [Abstract][Full Text] [Related]
4. Progression to acquired immunodeficiency syndrome in 94 human immunodeficiency virus-positive hemophiliacs with long-term follow-up.
Lorenzo JI; Moscardó F; López-Aldeguer J; Aznar JA
Haematologica; 2001 Mar; 86(3):291-6. PubMed ID: 11357820
[TBL] [Abstract][Full Text] [Related]
5. Pathological status and therapy of HIV-infected hemophiliacs in Japan.
Yamada K
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():127-30. PubMed ID: 1363705
[TBL] [Abstract][Full Text] [Related]
6. [Progression to AIDS among HIV-seropositive hemophiliacs].
Lorenzo JI; Molina R; Senent ML; Monzó E; Lerma MA; Dasí MA; Monteagudo E; Aznar JA
Sangre (Barc); 1992 Jun; 37(3):169-74. PubMed ID: 1440093
[TBL] [Abstract][Full Text] [Related]
7. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
8. CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates.
Goldsmith JM; Deutsche J; Tang M; Green D
Thromb Haemost; 1991 Oct; 66(4):415-9. PubMed ID: 1839091
[TBL] [Abstract][Full Text] [Related]
9. Concordance of human leukocyte antigen haplotype-sharing, CD4 decline and AIDS in hemophilic siblings. Multicenter Hemophilia Cohort and Hemophilia Growth and Development Studies.
Kroner BL; Goedert JJ; Blattner WA; Wilson SE; Carrington MN; Mann DL
AIDS; 1995 Mar; 9(3):275-80. PubMed ID: 7755916
[TBL] [Abstract][Full Text] [Related]
10. [Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].
Pezzotti P; Dorrucci M; Donisi A; Cusini M; Mazzarello G; De Luca A; Salassa B; Ursitti MA; Giuliani M; Rezza G;
Epidemiol Prev; 2003; 27(6):348-55. PubMed ID: 15058363
[TBL] [Abstract][Full Text] [Related]
11. Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study.
Rezza G; Galai N; Pezzotti P; Vlahov D; Graham NM; Viale P; Angarano G
Antivir Ther; 1997 Jul; 2(3):167-74. PubMed ID: 11322271
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of HIV infection and AIDS in a cohort of Italian hemophiliacs.
Sorice F; Ghirardini A; Martino P; Pasqualetti D; Annino L; Micozzi A; Cirelli A; Tamburrini E; Isacchi G; Buttò S
Haematologica; 1989; 74(2):149-54. PubMed ID: 2568323
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion.
Santagostino E; Gringeri A; Cultraro D; Tradati F; Siracusano L; Marinoni A; Mannucci PM
Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):371-80. PubMed ID: 7580830
[TBL] [Abstract][Full Text] [Related]
14. Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
Justice AC; Stein DS; Fusco GP; Sherrill BH; Fusco JS; Danehower SC; Becker SL; Hansen NI; Graham NM;
J Clin Epidemiol; 2004 Jan; 57(1):89-97. PubMed ID: 15019015
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia.
Sabin CA; Devereux HL; Clewley G; Emery VC; Phillips AN; Loveday C; Lee CA; Griffiths PD
J Infect Dis; 2000 May; 181(5):1800-3. PubMed ID: 10823788
[TBL] [Abstract][Full Text] [Related]
16. Early versus deferred zidovudine monotherapy: impact on AIDS-free time and survival in the multicenter AIDS cohort study.
Detels R; Muñoz A; Peng Y; Graham N; Mellors J; Phair J
Antivir Ther; 1997 Jan; 2(1):21-9. PubMed ID: 11322263
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study.
Dorrucci M; Pezzotti P; Phillips AN; Alliegro MB; Rezza G
AIDS; 1997 Mar; 11(4):461-7. PubMed ID: 9084793
[TBL] [Abstract][Full Text] [Related]
18. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
[TBL] [Abstract][Full Text] [Related]
19. Survival of patients with blood-borne AIDS in Italy.
Bellocco R; Xu J; Schinaia N; Arcieri R; Pagano M
J Epidemiol Biostat; 2000; 5(2):79-87. PubMed ID: 10890279
[TBL] [Abstract][Full Text] [Related]
20. The effect of antiviral therapy on the natural history of human immunodeficiency virus infection in a cohort of hemophiliacs.
Ragni MV; Kingsley LA; Zhou SJ
J Acquir Immune Defic Syndr (1988); 1992; 5(2):120-6. PubMed ID: 1732503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
